Kevin Keller

Kevin Keller, PhD, is currently the Director of Global Access Strategy Lead for Rare Diseases. They have held roles such as Senior Manager of Value and Access for the Oncology Pipeline and Director of Business Development at Amgen. Kevin's previous experience includes positions at Promidian and M Lebow & Associates, where they utilized their scientific background to assist in business development and market strategy. They have also contributed to academia as an adjunct professor and lecturer at Hofstra University and the University of California, Riverside. Kevin earned a PhD in Cell, Molecular, and Developmental Biology from the University of California, Riverside, following a Master's degree from Hofstra University and a Bachelor's degree from Cornell University.